BRIEF-Eiger says FDA orphan drug designation granted for pegylated interferon lambda in hepatitis delta virus infection
September 05, 2017 at 08:13 AM EDT
* Eiger announces FDA orphan drug designation granted for pegylated interferon lambda in hepatitis delta virus infection Source text for Eikon: Further company coverage:
